Men's health, low testosterone, and diabetes: individualized treatment and a multidisciplinary approach (Q34884322)

5 August 2017

Men's health, low testosterone, and diabetes: individualized treatment and a multidisciplinary approach (English)

1 reference

5 August 2017

1 reference

1 reference

Donna Rice

1

1 reference

5 August 2017

Robert E Brannigan

2

1 reference

5 August 2017

R Keith Campbell

3

1 reference

5 August 2017

Shari Fine

4

1 reference

5 August 2017

Leonard Jack

5

1 reference

5 August 2017

Joseph B Nelson

6

1 reference

5 August 2017

Janet Regan-Klich

7

1 reference

5 August 2017

1 November 2008

1 reference

The Science of Diabetes Self-Management and Care

5 August 2017

1 reference

5 August 2017

34 Suppl 5

1 reference

5 August 2017

97S-112S; quiz 113S-4S

1 reference

Male hypogonadism. Part I: Epidemiology of hypogonadism.

5 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Role of endogenous androgen against insulin resistance and athero- sclerosis in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Low serum testosterone concentration in middle-aged men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Measurement of testosterone in the diagnosis of hypogonadism in the ageing male

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Comparison of screening questionnaires for the diagnosis of hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Risks of testosterone-replacement therapy and recommendations for monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Testosterone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Recent trends in the treatment of testosterone deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Testosterone hormone replacement therapy: state-of-the-art and emerging technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Diagnosing and treating testosterone deficiency in different parts of the world. Results from global market research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

21 January 2018

Review of Testim gel.

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Testosterone replacement in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Testosterone deficiency: a common, unrecognized syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Androgens, insulin resistance and vascular disease in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Low testosterone levels are common and associated with insulin resistance in men with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Testosterone, diabetes mellitus, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Androgen deficiency as a predictor of metabolic syndrome in aging men: an opportunity for intervention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Endogenous sex hormones in men aged 40-80 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Low serum testosterone and mortality in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Male hypogonadism in systemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Testosterone and depression in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Invasive breast cancer after initiation of testosterone replacement therapy in a man--a warning to endocrinologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

ORIGINAL RESEARCH–EDUCATION: Frequency and Focus of Sexual History Taking in Male Patients—A Pilot Study Conducted among Swiss General Practitioners and Urologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Effect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

The triad of erectile dysfunction, hypogonadism and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

Use of an assessment tool to enhance diabetes educators' ability to identify erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

ANDROTEST: a structured interview for the screening of hypogonadism in patients with sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721708327143

21 January 2018

Identifiers

DOI

10.1177/0145721708327143

1 reference

5 August 2017

1 reference